These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30850736)

  • 1. A fully human anti-IL-7Rα antibody promotes antitumor activity against T-cell acute lymphoblastic leukemia.
    Akkapeddi P; Fragoso R; Hixon JA; Ramalho AS; Oliveira ML; Carvalho T; Gloger A; Matasci M; Corzana F; Durum SK; Neri D; Bernardes GJL; Barata JT
    Leukemia; 2019 Sep; 33(9):2155-2168. PubMed ID: 30850736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia.
    González-García S; Mosquera M; Fuentes P; Palumbo T; Escudero A; Pérez-Martínez A; Ramírez M; Corcoran AE; Toribio ML
    Blood; 2019 Dec; 134(24):2171-2182. PubMed ID: 31530562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New anti-IL-7Rα monoclonal antibodies show efficacy against T cell acute lymphoblastic leukemia in pre-clinical models.
    Hixon JA; Andrews C; Kashi L; Kohnhorst CL; Senkevitch E; Czarra K; Barata JT; Li W; Schneider JP; Walsh STR; Durum SK
    Leukemia; 2020 Jan; 34(1):35-49. PubMed ID: 31439943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of wild-type IL-7Rα promotes T-cell acute lymphoblastic leukemia/lymphoma.
    Silva A; Almeida ARM; Cachucho A; Neto JL; Demeyer S; de Matos M; Hogan T; Li Y; Meijerink J; Cools J; Grosso AR; Seddon B; Barata JT
    Blood; 2021 Sep; 138(12):1040-1052. PubMed ID: 33970999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CXCR3 ligands in IL-7/IL-7R alpha-Fc-mediated antitumor activity in lung cancer.
    Andersson A; Srivastava MK; Harris-White M; Huang M; Zhu L; Elashoff D; Strieter RM; Dubinett SM; Sharma S
    Clin Cancer Res; 2011 Jun; 17(11):3660-72. PubMed ID: 21636553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia.
    Zenatti PP; Ribeiro D; Li W; Zuurbier L; Silva MC; Paganin M; Tritapoe J; Hixon JA; Silveira AB; Cardoso BA; Sarmento LM; Correia N; Toribio ML; Kobarg J; Horstmann M; Pieters R; Brandalise SR; Ferrando AA; Meijerink JP; Durum SK; Yunes JA; Barata JT
    Nat Genet; 2011 Sep; 43(10):932-9. PubMed ID: 21892159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic targeting of IL-7Rα signaling pathways in ALL treatment.
    Cramer SD; Aplan PD; Durum SK
    Blood; 2016 Jul; 128(4):473-8. PubMed ID: 27268088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia.
    Ribeiro D; Melão A; Barata JT
    Adv Biol Regul; 2013 May; 53(2):211-22. PubMed ID: 23234870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-7 induces rapid clathrin-mediated internalization and JAK3-dependent degradation of IL-7Ralpha in T cells.
    Henriques CM; Rino J; Nibbs RJ; Graham GJ; Barata JT
    Blood; 2010 Apr; 115(16):3269-77. PubMed ID: 20190194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of human IL-7 receptor alpha expression by IL-7 and TCR signaling.
    Alves NL; van Leeuwen EM; Derks IA; van Lier RA
    J Immunol; 2008 Apr; 180(8):5201-10. PubMed ID: 18390701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-7R-Dependent Phosphatidylinositol 3-Kinase Competes with the STAT5 Signal to Modulate T Cell Development and Homeostasis.
    Cui G; Shimba A; Ma G; Takahara K; Tani-Ichi S; Zhu Y; Asahi T; Abe A; Miyachi H; Kitano S; Hara T; Yasunaga JI; Suwanai H; Yamada H; Matsuoka M; Ueki K; Yoshikai Y; Ikuta K
    J Immunol; 2020 Feb; 204(4):844-857. PubMed ID: 31924648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant IL7R collaborates with MYC to induce T-cell acute lymphoblastic leukemia.
    Oliveira ML; Veloso A; Garcia EG; Iyer S; Pereira C; Barreto VM; Langenau DM; Barata JT
    Leukemia; 2022 Jun; 36(6):1533-1540. PubMed ID: 35581375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-7: Comprehensive review.
    Winer H; Rodrigues GOL; Hixon JA; Aiello FB; Hsu TC; Wachter BT; Li W; Durum SK
    Cytokine; 2022 Dec; 160():156049. PubMed ID: 36201890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressor of cytokine signalling 3 is crucial for interleukin-7 receptor re-expression after T-cell activation and interleukin-7 dependent proliferation.
    Güler A; Lopez Venegas M; Adankwah E; Mayatepek E; Nausch N; Jacobsen M
    Eur J Immunol; 2020 Feb; 50(2):234-244. PubMed ID: 31621896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression analysis and characterization of alternatively spliced transcripts of human IL-7Ralpha chain encoding two truncated receptor proteins in relapsed childhood all.
    Korte A; Köchling J; Badiali L; Eckert C; Andreae J; Geilen W; Kebelmann-Betzing C; Taube T; Wu S; Henze G; Seeger K
    Cytokine; 2000 Nov; 12(11):1597-608. PubMed ID: 11052810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INPP5K controls the dynamic structure and signaling of wild-type and mutated, leukemia-associated IL-7 receptors.
    Moës B; Li H; Molina-Ortiz P; Radermecker C; Rosu A; Vande Catsyne CA; Sayyed SA; Fontela J; Duque M; Mostafa A; Azzi A; Barata JT; Merino R; Xu C; Desmet CJ; Schurmans S
    Blood; 2023 Apr; 141(14):1708-1717. PubMed ID: 36599086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effects of interleukin-7 and pre-T cell receptor signaling in human T cell development.
    Patel ES; Chang LJ
    J Biol Chem; 2012 Sep; 287(40):33826-35. PubMed ID: 22859301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update.
    Oliveira ML; Akkapeddi P; Ribeiro D; Melão A; Barata JT
    Adv Biol Regul; 2019 Jan; 71():88-96. PubMed ID: 30249539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-7 receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK inhibition.
    Courtois L; Cabannes-Hamy A; Kim R; Delecourt M; Pinton A; Charbonnier G; Feroul M; Smith C; Tueur G; Pivert C; Balducci E; Simonin M; Angel LH; Spicuglia S; Boissel N; Andrieu GP; Asnafi V; Rousselot P; Lhermitte L
    Blood; 2023 Jul; 142(2):158-171. PubMed ID: 37023368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of IgG2 Antibodies to Pneumococcal Polysaccharides After Vaccination of Treated HIV Patients May Be Augmented by IL-7Rα Signaling in ICOS
    Abudulai LN; Fernandez S; Corscadden K; Kirkham LA; Hunter M; Post JJ; French MA
    Front Immunol; 2019; 10():839. PubMed ID: 31068934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.